Drugs / gramicidine C
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06843018 | Nov 2024 → Dec 2026 expected | acute pharyngitis, nasopharyngitis | Valenta Pharm JSC | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gramicidine C | “gramicidine C + oxybuprocaine + cetylpyridine chloride” NCT06843018 ↗ |